Shanghai Healthcare Capital
Funding rounds backed by Shanghai Healthcare Capital.
- Funding disclosed in full
- $30M
- Median round
- $30M
- Rounds in calculation
- 1
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| Beyang Therapeutics AI-driven drug discovery company using its ExCEED molecular design platform | $30MSeries A | BiotechChina |